Last reviewed · How we verify
Clinique Saint-Jean, Bruxelles — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Ropivacaine Monohydrochloride | Ropivacaine Monohydrochloride | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels | Anesthesia |
Therapeutic area mix
- Anesthesia · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Başakşehir Çam & Sakura City Hospital · 1 shared drug class
- Bozyaka Training and Research Hospital · 1 shared drug class
- Bursa City Hospital · 1 shared drug class
- Centre of Postgraduate Medical Education · 1 shared drug class
- Complejo Hospitalario Universitario de Granada · 1 shared drug class
- Federal University of Minas Gerais · 1 shared drug class
- Fundacion Clinica Valle del Lili · 1 shared drug class
- Ain Shams University · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Clinique Saint-Jean, Bruxelles:
- Clinique Saint-Jean, Bruxelles pipeline updates — RSS
- Clinique Saint-Jean, Bruxelles pipeline updates — Atom
- Clinique Saint-Jean, Bruxelles pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Clinique Saint-Jean, Bruxelles — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/clinique-saint-jean-bruxelles. Accessed 2026-05-16.